Transient worsening of pemphigus vulgaris resembling toxic epidermal necrolysis after the first cycle of rituximab therapy

Dermatol Ther. 2022 Jun;35(6):e15469. doi: 10.1111/dth.15469. Epub 2022 Mar 30.

Authors

Mislav Mokos¹, Ines Lakoš Jukić^{1

2}, Branka Marinović^{1

2}

Affiliations

¹ School of Medicine, University of Zagreb, Zagreb, Croatia.
² Department of Dermatology and Venereology, University Hospital Centre Zagreb, Zagreb, Croatia.

PMID: 35332629
DOI: 10.1111/dth.15469

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Murine-Derived
Humans
Immunologic Factors / adverse effects
Pemphigus* / diagnosis
Pemphigus* / drug therapy
Rituximab / adverse effects
Stevens-Johnson Syndrome* / diagnosis
Stevens-Johnson Syndrome* / etiology

Substances

Antibodies, Monoclonal, Murine-Derived
Immunologic Factors
Rituximab